Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset Pompe disease patient fibroblasts
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP275680
下载链接
链接失效反馈官方服务：
资源简介：
human Pompe Disease (c.-32-13T>G) fibroblasts were exposed to 10 µM Deferoxamine (DFX) or 0.1% DMSO (control condition), for three days. Overall design: Three DMSO (CTR01Fib, CTR02Fib, CTR03Fib) and Deferoxamine (DFX04, DFX05, DFX06) independent treatments.
创建时间：
2021-01-22
